Results 31 to 40 of about 73,497 (258)
Insight into Prevention of Neisseria Gonorrhoeae: A Short Review
Vaccines, 2022 Neisseria gonorrhoeae (gonococcus) and Neisseria meningitidis (meningococcus) are important global pathogens which cause the sexually transmitted diseases gonorrhea and meningitis, respectively, as well as sepsis.
Vincenza La Fauci +3 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2021 Neisseria meningitidis serogroup B (MenB) is the most common cause of meningococcal disease in adolescents and young adults. In Australia, MenB vaccination has been available through private prescription since 2014 and has been recommended for at-risk ...
Juliana de Oliveira Costa +7 more
doaj +1 more source
Current status and challenges of meningococcal vaccines development in China
Zhongguo gonggong weisheng, 2022 Vaccination is the most effective and economical way to prevent meningococcal meningitis. In the past few decades, with widespread use of meningococcal vaccines, the incidence of meningococcal meningitis has dropped significantly. There are some vaccines
Ying-hua XU, Ya-nan LI, Qiang YE
doaj +1 more source
Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000-2008. [PDF]
, 2016 BackgroundAlthough human immunodeficiency virus (HIV) infection is an established risk factor for several bacterial infections, the association between HIV infection and meningococcal disease remains unclear.MethodsExpanded chart reviews were completed ...
Clark, Thomas A +17 more
core +2 more sources
Invasive Meningococcal Disease in the Vaccine Era
Frontiers in Pediatrics, 2018 Infection with the meningococcus is one of the main causes of meningitis and septicaemia worldwide. Humans are the only natural reservoir for the meningococcus which is found primarily as a commensal inhabitant in the nasopharynx in ~10% of adults, and ...
Simon Nadel, Nelly Ninis
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2020 Over the past 15 y, several vaccines have been added to the recommended immunization schedule for adolescents in the United States. In addition to annual influenza vaccination, the Advisory Committee on Immunization Practices recommends tetanus ...
Linda M. Niccolai, Caitlin E. Hansen
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 Booster doses of meningococcal conjugate vaccines induce long-term protection against invasive meningococcal disease. We evaluated the immunogenicity and safety of a booster dose of MenACYW-TT in pre-school children who were primed 3 years earlier with ...
Franco M. Piazza +11 more
doaj +1 more source
Post vaccinal temporary sensorineural hearing loss [PDF]
, 2018 In our systematic research we identified four studies concerning the onset of neurological adverse events following vaccination and two excluding this association.
De Cesare, Donato Pompeo +8 more
core +1 more source
Impact of serogroup A meningococcal conjugate vaccine for Africa
Human Vaccines & Immunotherapeutics, 2018 The introduction of a serogroup A meningococcal conjugate vaccine in the African meningitis belt has been a remarkable success. Meningitis due to the serogroup A meningococcus, previously responsible for most epidemics, has fallen by 99% in vaccinated ...
James M. Stuart
doaj +1 more source
Geographic correlation between deprivation and risk of meningococcal disease: an ecological study
BMC Public Health, 2004 Background Meningitis caused by Neisseria meningitidis is a serious infection which is most common in young children and adolescents. This study investigated the relationships between the incidence and age distribution of meningococcal disease, and ...
Lake Iain R +3 more
doaj +1 more source